CorNeat Vision Partners with LiveU and Alcon for Remote Surgeon Virtual Presence

CorNeat Vision, a clinical-stage, biomimetic implant and technology company, and LiveU, a company offering high-quality live video streaming and remote production solutions, announced today that they have partnered and successfully implemented an on-demand Remote Surgeon Virtual Presence (RSVP) solution.

The companies cooperated with Alcon to leverage its NGENUITY® 3D Visualization System to successfully perform remote supervised hands-on training of Canadian cornea experts located at the Kensington Eye Institute in Toronto, without leaving Israel. The solution, which was engineered to address COVID-19 travel restrictions, enabled initiation of the Canadian clinical site toward first implantations of the CorNeat KPro artificial cornea.

“With sub second latency, and a crisp, clear, hi-resolution, stereoscopic video signal projected to my Goovis 3D head-mounted display, it felt as if I beamed onto the objective lens of the remote ophthalmic microscope in Canada,” said Dr. Gilad Litvin, CorNeat Vision Founder, and Chief Medical Officer. “The RSVP solution is a game-changer in terms of our ability to expand our clinical trial to additional sites during the pandemic. Moreover, it will facilitate a smooth and efficient CorNeat KPro launch, as it will allow us to train physicians all over the world without leaving our office, helping us ramp up sales,” he added.

“It was as if Gilad was right here with me,” noted Prof. David Rootman, a world-renowned cornea expert and the Primary Investigator leading the Canadian artificial cornea clinical trial at the Toronto Western Hospital, part of the University Health Network. “Our ability to perform this training successfully is key in enabling us to initiate our trial without reliance on international travel,” he added.

“We are extremely excited to take part and assist in advancing CorNeat Vision’s clinical trial,” noted Ronen Artman, VP Marketing of LiveU. “LiveU’s reliable portable transmission solution enabled us to remotely connect to the microscope’s 3D video output without any technical assistance. While this unit alone enables streaming video for trainees, for example, the implementation of our bonded video decoder on the trainer side in Israel provided the low latency needed for the surgeons to interact in real-time while sharing a high-resolution 3D image.”

“The ability to stream high-resolution 3D video, critical in ophthalmic surgeries, directly from the operating room in real-time opens up a wide range of applications and use cases for us,” said Franck Leveiller, Senior Vice President, Head of Global Research and Development at Alcon, a global leader in the ophthalmology space and the provider of the NGENUITY 3D Visualization System.”

He added, “This innovative solution provides an additional added value to our customers, who can now leverage their investment to enable remote surgeon training, and remote expert supervision during live procedures. The RSVP solution is a true enabler during the pandemic. I’d like to thank our Canadian team and the surgical team at Lapidot Group, our Israeli distributor, for their support in making this a success.”

About the Remote Surgeon Virtual Presence (RSVP) solution: The RSVP solution is an on-demand video streaming solution that provides up to 4K video resolution in sub-second latency. The solution is comprised of a portable field unit and a decoder that bonds up to 16 cellular connections, multiple Wi-Fi networks, and a local area network to create a single managed high bandwidth connection that is optimized for video streaming. Coupled with Alcon NGENUITY 3D video output and a Goovis headset, this solution enables experts to “hop” into the operating room and provide their assistance and advice regardless of their geographical location.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”